<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2684">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04763941</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL20_0508</org_study_id>
    <nct_id>NCT04763941</nct_id>
  </id_info>
  <brief_title>Clinical Dementia Rating Medical Record</brief_title>
  <acronym>CLIMER</acronym>
  <official_title>Reliability of the Clinical Dementia Rating Scale From the Medical Record in Comparison With the Reference Method.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The assessment of severity of the cognitive and functional impairment is essential in the&#xD;
      follow-up of patients with neurocognitive disorders and in the assessment of the&#xD;
      effectiveness of therapeutics. However, the systematic assessment of the Clinical Dementia&#xD;
      Rating (CDR) scale is limited due to the time required to complete it (approximately 45 min&#xD;
      to 1 hour). Insofar as studies have shown correspondences between the CDR and scales&#xD;
      measuring cognitive and neuropsychological performance, and as part of memory consultations,&#xD;
      several functional and neuropsychological scales are systematically administered, we wish to&#xD;
      conduct a study validating the feasibility of the CDR based on information already available&#xD;
      in the patient's file compared to the evaluation of the CDR by the usual method (face-to-face&#xD;
      interview in consultation).&#xD;
&#xD;
      This study should highlight the feasibility of scoring the CDR-SB from the files of patients&#xD;
      in memory consultation, first in terms of reliability of the scores obtained compared to the&#xD;
      standard evaluation, and on the other hand in terms of organization and duration of&#xD;
      administration.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Actual">October 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CDR Sum of boxes (CDR-SB) score out of 18</measure>
    <time_frame>The CDR-SB score is collected at the baseline.</time_frame>
    <description>The CDR-SB score is obtained in normal condition and on file for the same patients. The CDR-SB score makes it possible to distinguish the following classes: 0 (normal), 0.5-4 (questionable cognitive impairment), 0.5-2.5 (questionable impairment), 3-4 (very mild major TNC or very mild dementia), 4.5- 9 (mild or mild dementia), 9.5-15.5 (moderate dementia), 16-18 (severe dementia).&#xD;
The patient's aptitudes are assessed in 6 different areas: 3 cognitive skills: memory, orientation and judgment, 3 acts of everyday living: participation in collective life, home occupations and hobbies, personal care.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Clinical Dementia Rating (CDR) From the Analysis of Medical Record</condition>
  <condition>Clinical Dementia Rating (CDR) Face-to-face Interview With the Patient</condition>
  <arm_group>
    <arm_group_label>Memory consultation patient</arm_group_label>
    <description>The study will be conducted on the basis of the patient consulting in Memory Consultation, specifically with the information already collected in normal care and the MEMORA cohort.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CDR assessment face-to-face</intervention_name>
    <description>The assessment of the CDR is administered once by a psychologist with the patient and his caregiver.</description>
    <arm_group_label>Memory consultation patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study will be conducted on the basis of the patient consulting in Memory Consultation,&#xD;
        specifically with the information already collected in normal care and the MEMORA cohort.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient who has CDR assessment in face-to-face interview during the memory&#xD;
             consultation,&#xD;
&#xD;
          -  Patient with an isolated cognitive complaint or a neurocognitive disorder&#xD;
&#xD;
          -  Patient included in the MEMORA cohort&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient or caregiver who does not wish their data to be used for research purposes&#xD;
             within the framework of the MEMORA cohort.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anthony Bathsavanis, Psy D</last_name>
    <role>Study Director</role>
    <affiliation>Hôpital des Charpennes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Krolak-Salmon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Edouard Herriot</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anthony Bathsavanis, Psy D</last_name>
    <phone>4 72 432 206</phone>
    <phone_ext>+33</phone_ext>
    <email>anthony.bathsavanis@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Virginie Dauphinot</last_name>
    <email>virginie.dauphinot@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Des Charpennes</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien Vernaudon, MD</last_name>
      <phone>4 72 432 227</phone>
      <phone_ext>+33</phone_ext>
      <email>julien.vernaudon@chu-lyon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2022</verification_date>
  <study_first_submitted>February 17, 2021</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2021</study_first_posted>
  <last_update_submitted>April 29, 2022</last_update_submitted>
  <last_update_submitted_qc>April 29, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CDR</keyword>
  <keyword>memory consultation</keyword>
  <keyword>patient's file</keyword>
  <keyword>reliability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

